Cefmetazole

Cefmetazole

Clinical data
AHFS/Drugs.com	International Drug Names
MedlinePlus	a601206
ATC code	J01DC09 (WHO)
Identifiers
IUPAC name (6R,7S)-7-(2-(cyanomethylthio)acetamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number	56796-20-4 Y
PubChem CID	42008
DrugBank	DB00274 Y
ChemSpider	38311 Y
UNII	3J962UJT8H
KEGG	D00910 Y
ChEBI	CHEBI:3489 Y
ChEMBL	ChEMBL1201195 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H17N7O5S3
Molar mass	471.538 g/mol
3D model (JSmol)	Interactive image
SMILES O=C2N1/C(=C(\CS[C@@H]1[C@]2(OC)NC(=O)CSCC#N)CSc3nnnn3C)C(=O)O
InChI InChI=1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1 Y Key:SNBUBQHDYVFSQF-HIFRSBDPSA-N Y
NY (what is this?)  (verify)

WikiDoc Resources for Cefmetazole
Articles
Most recent articles on Cefmetazole Most cited articles on Cefmetazole Review articles on Cefmetazole Articles on Cefmetazole in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefmetazole Images of Cefmetazole Photos of Cefmetazole Podcasts & MP3s on Cefmetazole Videos on Cefmetazole
Evidence Based Medicine
Cochrane Collaboration on Cefmetazole Bandolier on Cefmetazole TRIP on Cefmetazole
Clinical Trials
Ongoing Trials on Cefmetazole at Clinical Trials.gov Trial results on Cefmetazole Clinical Trials on Cefmetazole at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefmetazole NICE Guidance on Cefmetazole NHS PRODIGY Guidance FDA on Cefmetazole CDC on Cefmetazole
Books
Books on Cefmetazole
News
Cefmetazole in the news Be alerted to news on Cefmetazole News trends on Cefmetazole
Commentary
Blogs on Cefmetazole
Definitions
Definitions of Cefmetazole
Patient Resources / Community
Patient resources on Cefmetazole Discussion groups on Cefmetazole Patient Handouts on Cefmetazole Directions to Hospitals Treating Cefmetazole Risk calculators and risk factors for Cefmetazole
Healthcare Provider Resources
Symptoms of Cefmetazole Causes & Risk Factors for Cefmetazole Diagnostic studies for Cefmetazole Treatment of Cefmetazole
Continuing Medical Education (CME)
CME Programs on Cefmetazole
International
Cefmetazole en Espanol Cefmetazole en Francais
Business
Cefmetazole in the Marketplace Patents on Cefmetazole
Experimental / Informatics
List of terms related to Cefmetazole

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefmetazole is a cephamycin antibiotic, usually grouped with the second-generation cephalosporins.

Adverse effects

The chemical structure of cefmetazole, like that of several other cephalosporins, contains an N-methylthiotetrazole (NMTT or 1-MTT) side chain. As the antibiotic is broken down in the body, it releases free NMTT, which can cause hypoprothrombinemia (likely due to inhibition of the enzyme vitamin K epoxide reductase) and a reaction with ethanol similar to that produced by disulfiram (Antabuse), due to inhibition of aldehyde dehydrogenase.

Spectrum of bacterial susceptibility

Cefmetazole is a broad-spectrum cephalosporin antimicrobial and has been effective in treating bacteria responsible for causing urinary tract and skin infections. The following represents MIC susceptibility data for a few medically significant microorganisms.

• Bacteroides fragilis: 0.06 - >256 µg/ml
• Clostridium difficile: 8 - >128 µg/ml
• Staphylococcus aureus: 0.5 - 256 µg/ml (includes MRSA)